Cargando…
PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429257/ http://dx.doi.org/10.1097/01.HS9.0000975764.56696.bb |
| _version_ | 1785090666204758016 |
|---|---|
| author | Doddihal, Harsha Marron, Thomas C T, Satheesh Avaronnan, Manuprasad Nagarkar, Rajnish Gupta, Vineet Govinda Benjamin, Biju Gowda, Nagaraj Udupa, Venkatesha Biswas, Nilanjana Kadam, Jatin Dhage, Priyanka Beltran, Adam Amin, Nikhil |
| author_facet | Doddihal, Harsha Marron, Thomas C T, Satheesh Avaronnan, Manuprasad Nagarkar, Rajnish Gupta, Vineet Govinda Benjamin, Biju Gowda, Nagaraj Udupa, Venkatesha Biswas, Nilanjana Kadam, Jatin Dhage, Priyanka Beltran, Adam Amin, Nikhil |
| author_sort | Doddihal, Harsha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429257 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104292572023-08-17 PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. Doddihal, Harsha Marron, Thomas C T, Satheesh Avaronnan, Manuprasad Nagarkar, Rajnish Gupta, Vineet Govinda Benjamin, Biju Gowda, Nagaraj Udupa, Venkatesha Biswas, Nilanjana Kadam, Jatin Dhage, Priyanka Beltran, Adam Amin, Nikhil Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429257/ http://dx.doi.org/10.1097/01.HS9.0000975764.56696.bb Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Doddihal, Harsha Marron, Thomas C T, Satheesh Avaronnan, Manuprasad Nagarkar, Rajnish Gupta, Vineet Govinda Benjamin, Biju Gowda, Nagaraj Udupa, Venkatesha Biswas, Nilanjana Kadam, Jatin Dhage, Priyanka Beltran, Adam Amin, Nikhil PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. |
| title | PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. |
| title_full | PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. |
| title_fullStr | PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. |
| title_full_unstemmed | PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. |
| title_short | PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS. |
| title_sort | pb2258: phase 1 first in human study evaluating the safety, tolerability, pharmacokinetics and efficacy of grc54276, a novel hpk1 thronine-kinase inhibitor, in advanced solid tumours and lymphomas. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429257/ http://dx.doi.org/10.1097/01.HS9.0000975764.56696.bb |
| work_keys_str_mv | AT doddihalharsha pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT marronthomas pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT ctsatheesh pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT avaronnanmanuprasad pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT nagarkarrajnish pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT guptavineetgovinda pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT benjaminbiju pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT gowdanagaraj pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT udupavenkatesha pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT biswasnilanjana pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT kadamjatin pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT dhagepriyanka pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT beltranadam pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas AT aminnikhil pb2258phase1firstinhumanstudyevaluatingthesafetytolerabilitypharmacokineticsandefficacyofgrc54276anovelhpk1throninekinaseinhibitorinadvancedsolidtumoursandlymphomas |